# Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke

Study · id `cardio:ct-nct04285060` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04285060](<https://clinicaltrials.gov/study/NCT04285060>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04285060

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04285060. Allocation not applicable; no masking; primary purpose other. Start 2020-02-12 (actual); primary completion 2021-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04285060, source copy `cardio:ctgov-nct04285060-2021-09-27`, retrieved 2026-10-26)
- Started: 2020-02-12 (actual) (ClinicalTrials.gov record NCT04285060, source copy `cardio:ctgov-nct04285060-2021-09-27`, retrieved 2026-10-26)
- Primary completion: 2021-11 (anticipated) (ClinicalTrials.gov record NCT04285060, source copy `cardio:ctgov-nct04285060-2021-09-27`, retrieved 2026-10-26)
- Completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT04285060, source copy `cardio:ctgov-nct04285060-2021-09-27`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04285060, source copy `cardio:ctgov-nct04285060-2021-09-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04285060-2021-09-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke
- Condition: Stroke
- Condition: Chronic Stroke
- Intervention (Device): Samsung GEMS-H
- Lead sponsor: Samsung Electronics
- Lead sponsor class: INDUSTRY
- Collaborator: Shirley Ryan AbilityLab
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Shirley Ryan AbilityLab (`cardio:org-shirley-ryan-abilitylab`)

## Provenance

Content hash: bbb8fc3189c1c4de9474f23401798222e4cda104b9a7885a10611f68918731b9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
